INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 431m ago
House PTR31m ago
SEC 13F30m ago
Robinhood Chain30m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.72B / 19S · 11 late91 trades$22.97M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10CMCannon-Brookes Michael35B / 0S35 trades$11.72M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Grant or award
A—
34.2K sh
Jan 6, 2026Jan 8, 2026
Page 1557 of 1855
← PrevNext →
traded Jan 6, 2026
+2d
SEC Form 4

Evidence

17
HK
Henderson Tracey KExecutive VP Exploration
APAAPA Corp
Grant or award
A—
18.3K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$35K
9,722 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

17
EA
Edwards Carladenise ArmbristerDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
HC
Hamilton James CChief Medical Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
75.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
WC
Wu Joanne CGeneral Counsel and Secretary
AVOMission Produce, Inc.
Grant or award
A—
25.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
LW
Lopez Anthony WilliamSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
17.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
FJ
Frew JamesSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
55.8K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$33K
9,722 sh
Jan 8, 2026Jan 8, 2026
traded Jan 8, 2026
+0dSEC Form 4

Evidence

17
BK
Boone KarenDirector
CRWVCoreWeave, Inc.
Option exercise
M—
1,460 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Option exercise
M—
7,500 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

17
BB
Borgeson BlakeDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$959K
220.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

17
WM
Willis Eric M.See Remarks
AMPYAmplify Energy Corp.
Option exercise
M—
29.5K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

16
LM
Lakkundi Veena MPres, Performance Surfaces
APOGAPOGEE ENTERPRISES, INC.
Grant or award
A$50K
1,341 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

16
AD
Ajami DariushChief Innovation Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$194K
207.3K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

16
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Tax withholding
F$208K
17.6K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

16
FJ
Frew JamesSEE REMARKS
AMPYAmplify Energy Corp.
Tax withholding
F$109K
23.9K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

16
WM
Willis Eric M.See Remarks
AMPYAmplify Energy Corp.
Tax withholding
F$60K
13.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

16
WC
Wu Joanne CGeneral Counsel and Secretary
AVOMission Produce, Inc.
Tax withholding
F$149K
12.7K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

15
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$216K
1,121 sh
Jan 8, 2026Jan 8, 2026
traded Jan 8, 2026
+0dSEC Form 4

Evidence

15
HN
Haase Bruce NDirector
XPOFXponential Fitness, Inc.
Grant or award
A—
3,398 sh
Jan 1, 2026Jan 8, 2026
traded Jan 1, 2026
+7dSEC Form 4

Evidence

15
MA
Marathe AjayChief Operating Officer
ENVXEnovix Corp
Tax withholding
F$369K
42.6K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

15
PW
Peterson Neil W.CHIEF OPERATING OFFICER
MMSIMERIT MEDICAL SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$450K
5,000 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

15
WC
Wall Cecil CDirector
TMRCDyTb, LLC
Grant or award
A$18K
23.1K sh
Jan 5, 2026Jan 8, 2026
traded Jan 5, 2026
+3dSEC Form 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$234K
3,016 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

14
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
BK
Boone KarenDirector
CRWVCoreWeave, Inc.
Option exercise
M—
1,460 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
RG
Robinson William G JrDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
NP
Nelson Jonathan PChief Operations Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$30K
32.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
AS
Arnaboldi Nicole SDirector
NEENEXTERA ENERGY INC
Grant or award
A$36K
463 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Option exercise
M—
17.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
LU
Loengard Anna UDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
GR
Giroux RichardCFO & COO
MGTXMeiraGTx Holdings plc
Option exercise
M—
52.5K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
LA
Lufkin Paul AndrewSenior Vice President, Sales
BYNDBEYOND MEAT, INC.
Tax withholding
F$28K
30.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
LF
Lizzul Paul F.Chief Medical Officer
ANABANAPTYSBIO, INC
Option exercise
M—
6,145 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
FT
Foote TimChief Financial Officer
BBBLACKBERRY Ltd
Option exercise
M—
4,616 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Tax withholding
F$34K
4,364 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

13
AE
Ackerman EricaCAO and Corporate Controller
HYFMHYDROFARM HOLDINGS GROUP, INC.
Tax withholding
F$1,037
687 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$100K
2,843 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

13
KL
Kouzoukas Demetrios L.Director
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence